DANBURY, Conn.--(BUSINESS WIRE)--Praxair, Inc. (NYSE: PX) announced today that its subsidiary, Praxair Canada Inc., has received approval for the sale of its Noxivent brand of inhaled nitric oxide in Canada.
![]()
↧